Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 20, Issue 4, Pages e130-e134
http://dx.doi.org/10.1155/2009/871071
Original Article

Profile of Serogroup Y Meningococcal Infections in Canada: Implications for Vaccine Selection

Nicole Le Saux,1 Julie A Bettinger,2 Susan Wootton,3 Scott A Halperin,4 Wendy Vaudry,5 David W Scheifele,2 and Raymond Tsang6

1Children’s Hospital of Eastern Ontario Research Institute and the University of Ottawa, Ottawa, Ontario, Canada
2Vaccine Evaluation Center, BC Children’s Hospital and the University of British Columbia, Vancouver, British Columbia, Canada
3University of Texas Health Science Center, Houston, Texas, USA
4Clinical Trials Research Center, IWK Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada
5Stollery Children’s Hospital and University of Alberta, Edmonton, Alberta, Canada
6National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada

Copyright © 2009 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Nicole Le Saux, Julie A Bettinger, Susan Wootton, et al., “Profile of Serogroup Y Meningococcal Infections in Canada: Implications for Vaccine Selection,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 20, no. 4, pp. e130-e134, 2009. https://doi.org/10.1155/2009/871071.